Intended for healthcare professionals

  1. Research
  2. Prevalence of cervical...
  3. Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study
CCBYNC Open access
Research

Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study

BMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l1161 (Published 03 April 2019) Cite this as: BMJ 2019;365:l1161

Linked editorial

The remarkable impact of bivalent HPV vaccine in Scotland

Linked opinion

Bivalent HPV vaccine in Scotland is having a considerable and sustained effect

Data supplement

  • Web extra

    • Data Supplement - Supplementary table: Distribution of vaccination status and cytology and histology results by year of birth

Related articles

EditorialThe remarkable impact of bivalent HPV vaccine in Scotland
BMJ opinionBivalent HPV vaccine in Scotland is having a considerable and sustained effect
Editor's choiceHPV vaccination: triumphs and tribulations

See more

Cited by...

  • Trends in HPV Vaccination Initiation and Completion Within Ages 9-12 Years: 2008-2018
  • Cervical Pathology Following HPV Vaccination in Greece: A 10-year HeCPA Observational Cohort Study
  • The remarkable impact of bivalent HPV vaccine in Scotland
Back to top